These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 31797240)
1. Antithrombotic therapy for chronic coronary syndrome and atrial fibrillation: less might be more. Wernly B; Bhatt DL; Polzin A; Jung C J Thromb Thrombolysis; 2020 Feb; 49(2):321-324. PubMed ID: 31797240 [TBL] [Abstract][Full Text] [Related]
2. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis. Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242 [TBL] [Abstract][Full Text] [Related]
3. Meta-Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease. Ahmed M; Ahsan A; Shafiq A; Ahmed R; Alam M; Sabouret P; Rana JS; Fonarow GC Clin Cardiol; 2024 Oct; 47(10):e70026. PubMed ID: 39373259 [TBL] [Abstract][Full Text] [Related]
4. Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment. A meta-analysis. Chen CF; Chen B; Zhu J; Xu YZ Herz; 2015 Dec; 40(8):1070-83. PubMed ID: 26135462 [TBL] [Abstract][Full Text] [Related]
5. Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation. Lee SR; Rhee TM; Kang DY; Choi EK; Oh S; Lip GYH Am J Cardiol; 2019 Sep; 124(6):879-885. PubMed ID: 31311662 [TBL] [Abstract][Full Text] [Related]
6. Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: "OLTAT registry". Fischer Q; Georges JL; Le Feuvre C; Sharma A; Hammoudi N; Berman E; Cohen S; Jolivet I; Silvain J; Helft G Int J Cardiol; 2018 Aug; 264():64-69. PubMed ID: 29776575 [TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Cavallari I; Patti G Am J Cardiol; 2018 Mar; 121(6):718-724. PubMed ID: 29373105 [TBL] [Abstract][Full Text] [Related]
8. Antithrombotic therapy after acute ischemic stroke in patients with atrial fibrillation. McGrath ER; Kapral MK; Fang J; Eikelboom JW; Conghaile Aó; Canavan M; O'Donnell MJ; Stroke; 2014 Dec; 45(12):3637-42. PubMed ID: 25378422 [TBL] [Abstract][Full Text] [Related]
9. Meta-Analysis of Antithrombotic Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention. Khan SU; Khan MU; Ghani AR; Lone AN; Arshad A; Kaluski E Am J Cardiol; 2018 May; 121(10):1200-1206. PubMed ID: 29548674 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of single vs dual antiplatelet therapy in patients on anticoagulation undergoing percutaneous coronary intervention: A systematic review and meta-analysis. Atti V; Turagam MK; Garg J; Velagapudi P; Patel NJ; Basir MB; Mujer MT; Rayamajhi S; Abela GS; Koerber S; Gopinnathanair R; Lakkireddy D J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2460-2472. PubMed ID: 31432607 [TBL] [Abstract][Full Text] [Related]
11. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention. Olivier CB; Fan J; Askari M; Mahaffey KW; Heidenreich PA; Perino AC; Leef GC; Ho PM; Harrington RA; Turakhia MP Circ Cardiovasc Interv; 2019 Aug; 12(8):e007604. PubMed ID: 31416357 [TBL] [Abstract][Full Text] [Related]
12. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis. Haller PM; Sulzgruber P; Kaufmann C; Geelhoed B; Tamargo J; Wassmann S; Schnabel RB; Westermann D; Huber K; Niessner A; Gremmel T Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):226-236. PubMed ID: 31198930 [TBL] [Abstract][Full Text] [Related]
13. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of anticoagulant monotherapy in atrial fibrillation and stable coronary artery disease: A systematic review and meta-analysis. Ullah W; Sattar Y; Shaukat M; Fischman DL Eur J Intern Med; 2020 Nov; 81():54-59. PubMed ID: 32709546 [TBL] [Abstract][Full Text] [Related]
15. Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry. Xanthopoulou I; Dragona VM; Davlouros P; Tsioufis C; Iliodromitis E; Alexopoulos D; Cardiovasc Drugs Ther; 2018 Apr; 32(2):191-196. PubMed ID: 29679301 [TBL] [Abstract][Full Text] [Related]
16. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760 [TBL] [Abstract][Full Text] [Related]
17. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease. Cairns JA; McMurtry MS Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600 [TBL] [Abstract][Full Text] [Related]
18. Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation. Matsumura-Nakano Y; Shizuta S; Komasa A; Morimoto T; Masuda H; Shiomi H; Goto K; Nakai K; Ogawa H; Kobori A; Kono Y; Kaitani K; Suwa S; Aoyama T; Takahashi M; Sasaki Y; Onishi Y; Mano T; Matsuda M; Motooka M; Tomita H; Inoko M; Wakeyama T; Hagiwara N; Tanabe K; Akao M; Miyauchi K; Yajima J; Hanaoka K; Morino Y; Ando K; Furukawa Y; Nakagawa Y; Nakao K; Kozuma K; Kadota K; Kimura K; Kawai K; Ueno T; Okumura K; Kimura T; Circulation; 2019 Jan; 139(5):604-616. PubMed ID: 30586700 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies. Bavishi C; Koulova A; Bangalore S; Sawant A; Chatterjee S; Ather S; Valencia J; Sarafoff N; Rubboli A; Airaksinen JK; Lip GY; Tamis-Holland JE Catheter Cardiovasc Interv; 2016 Jul; 88(1):E12-22. PubMed ID: 26354765 [TBL] [Abstract][Full Text] [Related]
20. Dual Versus Triple Therapy in Patients with Acute Coronary Syndrome and an Anticoagulation Indication: A Systematic Review with Meta-Analysis and Trial-Sequential Analysis. Gupta R; Malik AH; Gupta R; Ranchal P; Yandrapalli S; Patel B; Frishman WH; Aronow WS; Garg J Cardiol Rev; 2021 Sep-Oct 01; 29(5):245-252. PubMed ID: 34001690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]